AAREY DRUGS & PHARMACEUTICALS
Back to All Ratios
|
AAREY DRUGS & PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 2.10 | 2.27 | 2.11 | 3.37 | 3.18 |
What is the latest Cash Earnings per Share (CEPS) ratio of AAREY DRUGS & PHARMACEUTICALS ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 2.10 |
| Mar2024 | 2.27 |
| Mar2023 | 2.11 |
| Mar2022 | 3.37 |
| Mar2021 | 3.18 |
How is Cash Earnings per Share (CEPS) of AAREY DRUGS & PHARMACEUTICALS Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 2.1 | -7.49 | |
| Mar2024 | 2.27 | 7.58 | |
| Mar2023 | 2.11 | -37.39 | |
| Mar2022 | 3.37 | 5.97 | |
| Mar2021 | 3.18 | - | |
Other Financial Ratios of AAREY DRUGS & PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of AAREY DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AAREY DRUGS & PHARMACEUTICALS | ₹223.9 Cr | -7.7% | 1.6% | 14.6% | Stock Analytics | |
| ADANI ENTERPRISES | ₹426,693.0 Cr | -0.1% | 7.1% | 25.8% | Stock Analytics | |
| PREMIER ENERGIES | ₹49,964.2 Cr | -1.6% | 4.3% | 1.5% | Stock Analytics | |
| AEGIS LOGISTICS | ₹45,603.7 Cr | 3.7% | 31.9% | 77.7% | Stock Analytics | |
| ADITYA INFOTECH | ₹44,765.5 Cr | 3.6% | 12.5% | NA | Stock Analytics | |
| REDINGTON | ₹21,592.6 Cr | -1.5% | 13.2% | -6.4% | Stock Analytics | |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AAREY DRUGS & PHARMACEUTICALS | -7.7% |
1.6% |
14.6% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses